Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Custom Truck One Source | CTOS | 3. mai 2024 | 4.17 | -14.90 |
Customers Bancorp | CUBI | 3. mai 2024 | 48.25 | +1.79 |
Customers Bancorp E Pref | CUBI-E | 3. mai 2024 | 25.58 | +0.17 |
Customers Bancorp F Pref | CUBI-F | 3. mai 2024 | 25.47 | +0.04 |
Cutera | CUTR | 3. mai 2024 | 2.53 | -1.56 |
CVB Financial | CVBF | 3. mai 2024 | 17.21 | +1.65 |
CVD Equipment | CVV | 3. mai 2024 | 4.45 | -1.55 |
CVR Energy | CVI | 3. mai 2024 | 29.49 | +0.20 |
Cvr Partners LP Unit | UAN | 3. mai 2024 | 80.75 | +1.71 |
CVRx | CVRX | 3. mai 2024 | 9.22 | +8.73 |
CVS Health | CVS | 3. mai 2024 | 55.90 | +1.36 |
CXApp A | CXAI | 3. mai 2024 | 3.37 | -2.03 |
CyberArk Software | CYBR | 3. mai 2024 | 227.32 | -2.66 |
Cybin | CYBN | 3. mai 2024 | 0.35 | 0.00 |
Cyclacel Pharmaceuticals | CYCC | 3. mai 2024 | 2.00 | -19.68 |
Cyclacel Pharmaceuticals Pref | CYCCP | 3. mai 2024 | 6.26 | -12.32 |
Cyclerion Therapeutics | CYCN | 3. mai 2024 | 2.96 | +4.79 |
Cyclo Therapeutics | CYTH | 3. mai 2024 | 1.51 | +2.72 |
Cyngn | CYN | 3. mai 2024 | 0.10 | -5.26 |
Cytek Biosciences | CTKB | 3. mai 2024 | 6.22 | +0.32 |
Cytokinetics | CYTK | 3. mai 2024 | 65.27 | +1.45 |
Cytomed Therapeutics | GDTC | 3. mai 2024 | 2.06 | -2.14 |
CytomX Therapeutics | CTMX | 3. mai 2024 | 4.43 | -1.56 |
Cytosorbents | CTSO | 3. mai 2024 | 0.88 | +7.40 |
D-MARKET Electronic Services & Trading ADR | HEPS | 3. mai 2024 | 1.46 | +0.69 |
D-Wave Quantum | QBTS | 3. mai 2024 | 1.40 | -3.45 |
D.R. Horton | DHI | 3. mai 2024 | 148.48 | +2.08 |
Dada Nexus ADR | DADA | 3. mai 2024 | 2.17 | +0.46 |
Daily Journal | DJCO | 3. mai 2024 | 369.00 | +2.46 |
Dakota Gold | DC | 3. mai 2024 | 2.45 | +1.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.